Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe.
Piek JJ, Boersma E, di Mario C, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Peels HO, Serruys PW. Piek JJ, et al. Among authors: haude m. Eur Heart J. 2000 Mar;21(6):466-74. doi: 10.1053/euhj.1999.1871. Eur Heart J. 2000. PMID: 10681487
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial.
Serruys PW, Hamburger JN, Koolen JJ, Fajadet J, Haude M, Klues H, Seabra-Gomes R, Corcos T, Hamm C, Pizzuli L, Meier B, Mathey D, Fleck E, Taeymans Y, Melkert R, Teunissen Y, Simon R. Serruys PW, et al. Among authors: haude m. Eur Heart J. 2000 Nov;21(21):1797-805. doi: 10.1053/euhj.2000.2263. Eur Heart J. 2000. PMID: 11052845 Clinical Trial.
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe.
Piek JJ, Boersma E, Voskuil M, di Mario C, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Peels HO, Serruys PW; DEBATE study group. Piek JJ, et al. Among authors: haude m. Eur Heart J. 2001 Sep;22(18):1725-32. doi: 10.1053/euhj.2000.2587. Eur Heart J. 2001. PMID: 11511122 Clinical Trial.
Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies.
Stegehuis VE, Wijntjens GWM, Bax M, Meuwissen M, Chamuleau SAJ, Voskuil M, Koch KT, Di Mario C, Vrints C, Haude M, Boersma E, Serruys PW, Piek JJ, van de Hoef TP. Stegehuis VE, et al. Among authors: haude m. EuroIntervention. 2021 Apr 2;16(18):e1503-e1510. doi: 10.4244/EIJ-D-19-00774. EuroIntervention. 2021. PMID: 31951205 Free PMC article.
Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe).
Serruys PW, di Mario C, Piek J, Schroeder E, Vrints C, Probst P, de Bruyne B, Hanet C, Fleck E, Haude M, Verna E, Voudris V, Geschwind H, Emanuelsson H, Mühlberger V, Danzi G, Peels HO, Ford AJ Jr, Boersma E. Serruys PW, et al. Among authors: haude m. Circulation. 1997 Nov 18;96(10):3369-77. doi: 10.1161/01.cir.96.10.3369. Circulation. 1997. PMID: 9396429 Clinical Trial.
Laser angioplasty of restenosed coronary stents: results of a multicenter surveillance trial. The Laser Angioplasty of Restenosed Stents (LARS) Investigators.
Köster R, Hamm CW, Seabra-Gomes R, Herrmann G, Sievert H, Macaya C, Fleck E, Fischer K, Bonnier JJ, Fajadet J, Waigand J, Kuck KH, Henry M, Morice MC, Pizzulli L, Webb-Peploe MM, Buchwald AB, Ekström L, Grube E, Al Kasab S, Colombo A, Sanati A, Ernst SM, Haude M, Serruys PW, et al. Köster R, et al. Among authors: haude m. J Am Coll Cardiol. 1999 Jul;34(1):25-32. doi: 10.1016/s0735-1097(99)00167-9. J Am Coll Cardiol. 1999. PMID: 10399988 Free article. Clinical Trial.
The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stent.
Grundeken MJ, White RM, Hernandez JB, Dudek D, Cequier A, Haude M, van Boven AJ, Piek JJ, Helqvist S, Sabate M, Baumbach A, Suwannasom P, Ishibashi Y, Staehr P, Veldhof S, Cheong WF, de Winter RJ, Garcia-Garcia HM, Wykrzykowska JJ, Onuma Y, Serruys PW, Chevalier B. Grundeken MJ, et al. Among authors: haude m. Eur Heart J Qual Care Clin Outcomes. 2016 Apr 1;2(2):108-116. doi: 10.1093/ehjqcco/qcv022. Eur Heart J Qual Care Clin Outcomes. 2016. PMID: 29474621
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).
Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA. Serruys PW, et al. Among authors: haude m. Lancet. 1998 Aug 29;352(9129):673-81. doi: 10.1016/s0140-6736(97)11128-x. Lancet. 1998. PMID: 9728982 Clinical Trial.
394 results